New study explores combining cancer and blood vessel surgery for advanced gynecologic tumors
NCT ID NCT07267780
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well patients do after surgery that removes both advanced gynecologic cancers and the major blood vessels they have grown into. Researchers will track 130 participants for up to 5 years to see survival rates and how long it takes for the cancer to return. The goal is to gather information to help guide future treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.R.N.A.S. Ospedali Civico Di Cristina Benfratell
Palermo, Italy, Italy
-
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, Campania, 80131, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can a natural compound boost chemotherapy against endometrial cancer?
- Can a new nucleotide analogue boost cancer treatment?
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- Scientists probe hidden clues to immunotherapy success in endometrial cancer